Fig. 1From: A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)Treatment plan of the study, including all visits, cycles, labs and tests needed for monitoringBack to article page